Detailed answers about RS MEDICAL, TRAINING AND SIMULATION LIMITED, including incorporation, status, business activity, and accounts information.
When was RS MEDICAL, TRAINING AND SIMULATION LIMITED founded?
RS MEDICAL, TRAINING AND SIMULATION LIMITED was officially incorporated on 2 August 2024 and is registered under company number 15871828. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is RS MEDICAL, TRAINING AND SIMULATION LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of RS MEDICAL, TRAINING AND SIMULATION LIMITED?
RS MEDICAL, TRAINING AND SIMULATION LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does RS MEDICAL, TRAINING AND SIMULATION LIMITED do?
RS MEDICAL, TRAINING AND SIMULATION LIMITED operates in the following sectors: 86900 - Other human health activities, 90020 - Support activities to performing arts. These SIC codes provide insight into the company's business activities and industry focus.
What is RS MEDICAL, TRAINING AND SIMULATION LIMITED's registered address?
The registered office address of RS MEDICAL, TRAINING AND SIMULATION LIMITED is 7C HANHAM HALL, WHITTUCKS ROAD, HANHAM, BRISTOL, UNITED KINGDOM, BS15 3FR. This is the official address filed with Companies House for legal and statutory correspondence.
Is RS MEDICAL, TRAINING AND SIMULATION LIMITED financially stable?
Financial accounts for RS MEDICAL, TRAINING AND SIMULATION LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.